AU4556800A - Novel treatment - Google Patents

Novel treatment

Info

Publication number: AU4556800A
Authority: AU; Australia
Prior art keywords: novel treatment; novel; treatment
Prior art date: 1999-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU45568/00A

Inventor

Elaine Alison Irving

Andrew A. Parsons

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-27

Filing date

2000-04-26

Publication date

2000-11-10

1999-04-27 Priority claimed from GBGB9909650.5A external-priority patent/GB9909650D0/en

1999-07-15 Priority claimed from GBGB9916655.5A external-priority patent/GB9916655D0/en

2000-04-26 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

2000-11-10 Publication of AU4556800A publication Critical patent/AU4556800A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU45568/00A 1999-04-27 2000-04-26 Novel treatment Abandoned AU4556800A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9909650.5A GB9909650D0 (en)	1999-04-27	1999-04-27	Novel treatment
GB9909650		1999-04-27
GB9916655		1999-07-15
GBGB9916655.5A GB9916655D0 (en)	1999-07-15	1999-07-15	Novel treatment
PCT/EP2000/003730 WO2000064422A2 (en)	1999-04-27	2000-04-26	Novel treatment of neurotraumatic conditions with raf inhibitor

Publications (1)

Publication Number	Publication Date
AU4556800A true AU4556800A (en)	2000-11-10

Family

ID=26315478

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU45568/00A Abandoned AU4556800A (en)	1999-04-27	2000-04-26	Novel treatment

Country Status (4)

Country	Link
EP (1)	EP1173254A2 (en)
JP (1)	JP2002542280A (en)
AU (1)	AU4556800A (en)
WO (1)	WO2000064422A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE382044T1 (en)	1999-11-22	2008-01-15	Smithkline Beecham Plc	IMIDAZOLE DERIVATIVES
US7446106B2 (en)	2001-09-05	2008-11-04	Smithkline Beecham Plc	Pyridylfurans and pyrroles as Raf kinase inhibitors
GB0121488D0 (en) *	2001-09-05	2001-10-24	Smithkline Beecham Plc	Compounds
EP1539121A4 (en)	2002-08-29	2008-08-13	Scios Inc	Methods of promoting osteogenesis
US7244441B2 (en)	2003-09-25	2007-07-17	Scios, Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
CA2568756A1 (en) *	2004-06-15	2005-12-29	Astrazeneca Ab	Substituted quinazolones as anti-cancer agents
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
TW200639163A (en)	2005-02-04	2006-11-16	Genentech Inc	RAF inhibitor compounds and methods
UA103319C2 (en)	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0554247B1 (en) *	1990-05-10	2000-04-26	Pfizer Inc.	Neuroprotective indolone and related derivatives
US5498610A (en) *	1992-11-06	1996-03-12	Pfizer Inc.	Neuroprotective indolone and related derivatives
AU6080294A (en) *	1992-12-31	1994-08-15	Texas Biotechnology Corporation	Antisense molecules directed against genes of the (raf) oncogene family
GB2306108A (en) *	1995-10-13	1997-04-30	Merck & Co Inc	Treatment of Raf-mediated cancers with imidazole derivatives
EP0889887A4 (en) *	1996-03-25	2003-06-11	Smithkline Beecham Corp	Novel treatment for cns injuries
WO1998022608A2 (en) *	1996-11-18	1998-05-28	Mcgill University	Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
GB9716557D0 (en) *	1997-08-06	1997-10-08	Glaxo Group Ltd	Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
US6022884A (en) *	1997-11-07	2000-02-08	Amgen Inc.	Substituted pyridine compounds and methods of use

2000
- 2000-04-26 JP JP2000613413A patent/JP2002542280A/en active Pending
- 2000-04-26 AU AU45568/00A patent/AU4556800A/en not_active Abandoned
- 2000-04-26 EP EP00927054A patent/EP1173254A2/en not_active Withdrawn
- 2000-04-26 WO PCT/EP2000/003730 patent/WO2000064422A2/en active Search and Examination

Also Published As

Publication number	Publication date
WO2000064422A3 (en)	2001-03-01
WO2000064422A2 (en)	2000-11-02
JP2002542280A (en)	2002-12-10
EP1173254A2 (en)	2002-01-23

Publication	Publication Date	Title
AU1173201A (en)	2001-05-14	Skin-gripper
AU3092999A (en)	2000-10-04	Digital-timeshare-exchange
AU2001271434A1 (en)	2003-01-08	Novel skateboard-bicycle combination
AU5089400A (en)	2000-12-28	Arthritis treatment
AU4431000A (en)	2000-12-05	Novel use
GB9925136D0 (en)	1999-12-22	Novel treatment
AU5967600A (en)	2001-02-13	Candystraw
PL349347A1 (en)	2002-07-15	Novel treatment
AU6335000A (en)	2001-04-24	Depthimeter
AU4115400A (en)	2000-11-14	Short-circuiter
AU5547000A (en)	2001-01-02	Novel treatment
AU2804600A (en)	2000-09-04	Arylaminoalkylamides
AU6440900A (en)	2001-03-13	Homogentisate-dioxygenase
AU2023701A (en)	2001-06-18	Sketcher
AU4556800A (en)	2000-11-10	Novel treatment
AU2699800A (en)	2000-09-04	Organoceramics
AU6098300A (en)	2001-02-05	Follistatin-3
AU4916900A (en)	2000-12-05	Benzofuranylsulfonates
AU2359301A (en)	2001-06-04	Novel ss-defensins
AU1038501A (en)	2001-04-30	Novel processes
AU7273000A (en)	2001-03-19	Novel processes
AU4561600A (en)	2000-12-05	Benzofuranylaminoalcohols
AU4456800A (en)	2000-11-02	Human hac3
AU1901801A (en)	2001-05-30	Glucofuranoses
AU7303400A (en)	2001-04-24	Osseo-distractor

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase